Computation Dosimetry of Radioligand Therapy Using Spatial Transcriptomics
Numerous radioligand therapy (RLT) agents are under various stages of development for treating late-stage cancers. We developed a computational methodology for identifying promising targets for RLT based on spatial transcriptomics analysis of tumor tissue.
Proffered Program · Radiopharmaceuticals, Theranostics, and Nuclear Medicine